Advanced search
Publication Cover
OncoImmunology Volume 9, 2020 - Issue 1
Submit an article Journal homepage
2,701
Views
13
CrossRef citations to date
0
Altmetric
Research Article

Tumors escape immunosurveillance by overexpressing the proteasome activator PSME3

Mathilde Boulpicantea Immunologie des Tumeurs et Immunothérapie, Université Paris-Saclay, Institut Gustave Roussy, Inserm, Villejuif, FranceView further author information
,
Romain Darrigranda Immunologie des Tumeurs et Immunothérapie, Université Paris-Saclay, Institut Gustave Roussy, Inserm, Villejuif, FranceView further author information
,
Alison Piersona Immunologie des Tumeurs et Immunothérapie, Université Paris-Saclay, Institut Gustave Roussy, Inserm, Villejuif, FranceView further author information
,
Valérie Salguesa Immunologie des Tumeurs et Immunothérapie, Université Paris-Saclay, Institut Gustave Roussy, Inserm, Villejuif, FranceView further author information
,
Marine Rouillona Immunologie des Tumeurs et Immunothérapie, Université Paris-Saclay, Institut Gustave Roussy, Inserm, Villejuif, FranceView further author information
,
Benoit Gaudineaub Dynamique des Cellules Tumorales, Université Paris-Saclay, Institut Gustave Roussy, Inserm, Villejuif, FranceView further author information
,
Mehdi Khaledb Dynamique des Cellules Tumorales, Université Paris-Saclay, Institut Gustave Roussy, Inserm, Villejuif, FranceView further author information
,
Angela Cattaneoc IFOM, The FIRC Institute of Molecular Oncology, Milano, ItalyView further author information
,
Angela Bachic IFOM, The FIRC Institute of Molecular Oncology, Milano, ItalyView further author information
,
Paolo Casciod Department of Veterinary Sciences, University of Turin, 10095, Grugliasco, Turin, ItalyView further author information
&
Sébastien Apchera Immunologie des Tumeurs et Immunothérapie, Université Paris-Saclay, Institut Gustave Roussy, Inserm, Villejuif, FranceCorrespondence[email protected]
View further author information
 show all
Article: 1761205 | Received 15 Nov 2019, Accepted 03 Apr 2020, Published online: 21 May 2020

Citations (13)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Ya Li, Juan Chen, Min Xie, Yihui Cao, Yan Zhou & Ruixian Zhang. (2023) Identification of a circRNA-miRNA-mRNA network to explore the effects of circRNAs on renal injury in systemic lupus erythematosus. Autoimmunity 56:1.
Read now

Articles from other publishers (12)

Adrian Schmalen, Ilona E. Kammerl, Silke Meiners, Elfriede Noessner, Cornelia A. Deeg & Stefanie M. Hauck. (2023) A Lysine Residue at the C-Terminus of MHC Class I Ligands Correlates with Low C-Terminal Proteasomal Cleavage Probability. Biomolecules 13:9, pages 1300.
Crossref
Anoop Kallingal, Mateusz Olszewski, Natalia Maciejewska, Wioletta Brankiewicz & Maciej Baginski. (2023) Cancer immune escape: the role of antigen presentation machinery. Journal of Cancer Research and Clinical Oncology 149:10, pages 8131-8141.
Crossref
Aaron Javitt, Merav D. Shmueli, Matthias P. Kramer, Aleksandra A. Kolodziejczyk, Ivan J. Cohen, Lihi Radomir, Daoud Sheban, Iris Kamer, Kevin Litchfield, Elizabeta Bab-Dinitz, Oranit Zadok, Vanessa Neiens, Adi Ulman, Hila Wolf-Levy, Avital Eisenberg-Lerner, Assaf Kacen, Michal Alon, Ana Toste Rêgo, Elvira Stacher-Priehse, Michael Lindner, Ina Koch, Jair Bar, Charles Swanton, Yardena Samuels, Yishai Levin, Paula C. A. da Fonseca, Eran Elinav, Nir Friedman, Silke Meiners & Yifat Merbl. (2023) The proteasome regulator PSME4 modulates proteasome activity and antigen diversity to abrogate antitumor immunity in NSCLC. Nature Cancer 4:5, pages 629-647.
Crossref
Grazia R. Tundo, Paolo Cascio, Danilo Milardi, Anna Maria Santoro, Grazia Graziani, Pedro Miguel Lacal, Alessio Bocedi, Francesco Oddone, Mariacristina Parravano, Andrea Coletta, Massimo Coletta & Diego Sbardella. (2023) Targeting immunoproteasome in neurodegeneration: A glance to the future. Pharmacology & Therapeutics 241, pages 108329.
Crossref
Chiao-Hsu Ke, Yi-Han Chiu, Kuo-Chin Huang & Chen-Si Lin. (2022) Exposure of Immunogenic Tumor Antigens in Surrendered Immunity and the Significance of Autologous Tumor Cell-Based Vaccination in Precision Medicine. International Journal of Molecular Sciences 24:1, pages 147.
Crossref
Dan-Dan Chen, Jia Hao, Chao-Hui Shen, Xian-Ming Deng & Cai-Hong Yun. (2022) Atomic resolution Cryo-EM structure of human proteasome activator PA28γ. International Journal of Biological Macromolecules 219, pages 500-507.
Crossref
Zhen Yu, Xiaojing Wei, Lanting Liu, Hao Sun, Teng Fang, Lu Wang, Ying Li, Weiwei Sui, Kefei Wang, Yi He, Yaozhong Zhao, Wenyang Huang, Gang An, Fancui Meng, Changjiang Huang, Tengteng Yu, Kenneth C. Anderson, Tao Cheng, Lugui Qiu & Mu Hao. (2022) Indirubin-3’-monoxime acts as proteasome inhibitor: Therapeutic application in multiple myeloma. eBioMedicine 78, pages 103950.
Crossref
Jean-Yves Alejandro Frayssinhes, Fulvia Cerruti, Justine Laulin, Angela Cattaneo, Angela Bachi, Sebastien Apcher, Olivier Coux & Paolo Cascio. (2021) PA28γ–20S proteasome is a proteolytic complex committed to degrade unfolded proteins. Cellular and Molecular Life Sciences 79:1.
Crossref
Zaur M. Kachaev, Sergey D. Ivashchenko, Eugene N. Kozlov, Lyubov A. Lebedeva & Yulii V. Shidlovskii. (2021) Localization and Functional Roles of Components of the Translation Apparatus in the Eukaryotic Cell Nucleus. Cells 10:11, pages 3239.
Crossref
Ran Jia, Zhilin Sui, Hongdian Zhang & Zhentao Yu. (2021) Identification and Validation of Immune-Related Gene Signature for Predicting Lymph Node Metastasis and Prognosis in Lung Adenocarcinoma. Frontiers in Molecular Biosciences 8.
Crossref
Paolo Cascio. (2021) PA28γ: New Insights on an Ancient Proteasome Activator. Biomolecules 11:2, pages 228.
Crossref
Zhen Yu, Lanting Liu, Kefei Wang, Hao Sun, Xiaojing We, Weiwei Sui, Teng Fang, Lu Wang, Ying Li, Yaozhong Zhao, Yi He, Wenyang Huang, Gang An, Fancui Meng, Changjiang Huang, Tengteng Yu, Kenneth. C. Anderson, Tao Cheng, Lugui Qiu & Mu Hao. (2021) Indirubin-3’-Monoxime Acts as a Novel Proteasome Inhibitor: Therapeutic Application in Multiple Myeloma. SSRN Electronic Journal.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.